Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MEDIC ADVICE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 3.3% 3.3%   Bankruptcy risk   2.6% 2.4% 2.9% 3.7% 12.2% 3.7% 9.4% 9.4%   Credit score (0-100)   63 65 58 50 18 51 26 26   Credit rating   BBB BBB BBB BBB BB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   492 493 200 194 132 163 0.0 0.0   EBITDA   448 392 200 194 132 163 0.0 0.0   EBIT   448 392 200 194 132 163 0.0 0.0   Pre-tax profit (PTP)   360.0 1,164.0 1,165.0 3,868.4 -1,969.2 -409.7 0.0 0.0   Net earnings   279.0 907.0 903.0 3,011.5 -1,972.3 -409.7 0.0 0.0   Pre-tax profit without non-rec. items   360 1,164 1,165 3,868 -1,969 -410 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   3,625 4,424 5,216 5,368 3,281 2,804 2,304 2,304   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,943 4,994 5,879 7,295 4,296 2,888 2,304 2,304   Net Debt   -3,656 -4,693 -5,625 -6,361 -3,923 -2,443 -2,304 -2,304     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   492 493 200 194 132 163 0.0 0.0   Gross profit growth   51.4% 0.2% -59.4% -3.0% -32.0% 23.9% -100.0% 0.0%   Employees   0 1 0 0 0 0 0 0   Employee growth %   0.0% 0.0% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,943 4,994 5,879 7,295 4,296 2,888 2,304 2,304   Balance sheet change%   5.5% 26.7% 17.7% 24.1% -41.1% -32.8% -20.2% 0.0%   Added value   448.0 392.0 200.0 194.0 131.9 163.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   91.1% 79.5% 100.0% 100.0% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   18.1% 28.7% 23.1% 60.0% 3.8% 7.0% 0.0% 0.0%   ROI %   19.6% 31.9% 26.0% 74.7% 5.1% 8.3% 0.0% 0.0%   ROE %   7.9% 22.5% 18.7% 56.9% -45.6% -13.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   91.9% 88.6% 88.7% 73.6% 76.4% 97.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -816.1% -1,197.2% -2,812.5% -3,278.4% -2,974.2% -1,494.7% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   12.4 8.8 8.9 3.8 4.2 34.4 0.0 0.0   Current Ratio   12.4 8.8 8.9 3.8 4.2 34.4 0.0 0.0   Cash and cash equivalent   3,656.0 4,693.0 5,625.0 6,360.9 3,923.3 2,443.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   377.0 466.0 -406.0 -983.5 333.6 609.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 392 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 392 0 0 0 0 0 0   EBIT / employee   0 392 0 0 0 0 0 0   Net earnings / employee   0 907 0 0 0 0 0 0